Evaluation of ocular neuropathic pain

DTM Le, H Kandel, SL Watson - The Ocular Surface, 2023 - Elsevier
Aim To identify and assess the quality of current validated questionnaires that could be used
to evaluate ocular neuropathic pain and its associated aetiologies. Methods A literature …

Corneal neuropathic pain: a review to inform clinical practice

SL Watson, DTM Le - Eye, 2024 - nature.com
Corneal neuropathic pain (CNP) is a poorly defined disease entity characterised by an
aberrant pain response to normally non-painful stimuli and categorised into having …

Serum-derived extracellular vesicles for the treatment of severe ocular surface disease

N Saraf, RA Ramachandran, M Cao, A Lemoff… - The Ocular Surface, 2024 - Elsevier
Purpose Autologous serum is widely used for the treatment of severe ocular surface disease
with mixed efficacy. Extracellular vesicles (EVs) are small membrane bound structures …

Association of dry eye diseases and auditory sensitivity

KW Kim, JS Hwang, J Chang, YJ Shin - Journal of Clinical Medicine, 2022 - mdpi.com
This study aimed to evaluate the association between dry eye and inner ear diseases in a
Korean population. Methods: Data from the Korean National Health and Nutrition Survey …

Corneal Neuropathic Pain: A Patient and Physician Perspective

TW McNally, FC Figueiredo - Ophthalmology and Therapy, 2024 - Springer
Corneal neuropathic pain (CNP) is a debilitating condition characterized by pain in the
absence of a noxious stimulus. Symptoms such as ocular stinging, burning, photophobia …

Effective Modulation by Lacosamide on Cumulative Inhibition of INa during High-Frequency Stimulation and Recovery of INa Block during Conditioning Pulse Train

PM Wu, YC Lin, CW Chiang, HY Cho… - International journal of …, 2022 - mdpi.com
The effects of lacosamide (LCS, Vimpat®), an anti-convulsant and analgesic, on voltage-
gated Na+ current (I Na) were investigated. LCS suppressed both the peak (transient, I Na …